Low-dose intranasal versus oral midazolam for routine body MRI of claustrophobic patients

European Radiology

Volumn 17, Issue 6, 2007, Pages 1403-1410

  Tschirch, Frank T C ^a   Göpfert, Kerstin ^a   Fröhlich, Johannes M ^b   Brunner, Genevieve ^a   Weishaupt, Dominik ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Klus Apotheke   (Switzerland)

Author keywords

Administration; Intranasal; Magnetic resonance imaging; Midazolam; Phobic disorders

Indexed keywords

MIDAZOLAM; MIDAZOLAM MALEATE;

ADULT; ANXIETY; ARTICLE; BURNING SENSATION; CLAUSTROPHOBIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; IMAGE QUALITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEDATION; TRANQUILIZING ACTIVITY; VISUAL ANALOG SCALE; WHOLE BODY MRI;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANXIETY; AROUSAL; CHI-SQUARE DISTRIBUTION; CONSCIOUS SEDATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MAGNETIC RESONANCE IMAGING; MALE; MIDAZOLAM; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PHOBIC DISORDERS; POSTURE; PROSPECTIVE STUDIES; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 34248660248     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-006-0457-1     Document Type: Article

References (18)

1. Melendez JC, McCrank E (1993) Anxiety-related reactions associated with magnetic resonance imaging examinations. JAMA 270(6):745-747
2. Hollenhorst J, Munte S, Friedrich L, Heine J, Leuwer M, Becker H, Piepenbrock S (2001) Using intranasal midazolam spray to prevent claustrophobia induced by MR imaging. AJR Am J Roentgenol 176(4):865-868
3. Schweizer E, Clary C, Dever AI, Mandos LA (1992) The use of low-dose intranasal midazolam to treat panic disorder: A pilot study. J Clin Psychiatry 53(1):19-22
4. Walbergh EJ, Wills RJ, Eckhert J (1991) Plasma concentrations of midazolam in children following intranasal administration. Anesthesiology 74(2):233-235
5. Harbord MG, Kyrkou NE, Kyrkou MR, Kay D, Coulthard KP (2004) Use of intranasal midazolam to treat acute seizures in paediatric community settings. J Paediatr Child Health 40(9-10):556-558
6. Lloyd CJ, Alredy T, Lowry JC (2000) Intranasal midazolam as an alternative to general anaesthesia in the management of children with oral and maxillofacial trauma. Br J Oral Maxillofac Surg 38(6):593-595
7. Uygur-Bayramicli O, Dabak R, Kuzucuoglu T, Kavakli B (2002) Sedation with intranasal midazolam in adults undergoing upper gastrointestinal endoscopy. J Clin Gastroenterol 35(2):133-137
8. Bjorkman S, Rigemar G, Idvall J (1997) Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients. Br J Anaesth 79(5):575-580
9. Burstein AH, Modica R, Hatton M, Forrest A, Gengo FM (1997) Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration. J Clin Pharmacol 37(8):711-718
10. Merrick PA, Ramsby GR (1994) Conscious sedation for imaging and interventional studies. Radiol Manage 16(2):35-40
11. Nordt SP, Clark RF (1997) Midazolam: A review of therapeutic uses and toxicity. J Emerg Med 15(3):357-365
12. Reed MD, Rodarte A, Blumer JL, Khoo KC, Akbari B, Pou S, Kearns GL; Pediatric Pharmacology Research Unit Network (2001) The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration. J Clin Pharmacol 41(12):1359-1369
13. Biro P, Weidmann G, Pietzsch S, Alon E, Brugger P (1997) [The dose-dependent effects of oral premedication with midazolam]. Anasthesiol Intensivmed Notfallmed Schmerzther 32(11):672-677
14. Moss ML, Buongiorno PA, Clancy VA (1993) Intranasal midazolam for claustrophobia in MRI. J Comput Assist Tomogr 17(6):991-992
15. Knoester PD, Jonker DM, van der Hoeven RTM, Venneij TAC, Edelbrock PM, Brekelmans GJ, de Haan GJ (2002) Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Br J Clin Pharmacol 53(5):501-507
16. Merkus F, Lehr C (2004) Intranasale Applikation von Arzneistoffen mit systemischer Wirkung. Deutsche Apotheker Zeitung 144(4):61-65
17. Fischer S, Renz D, Kleinstuck J, Schaper W, Karliczek GF (2004) [In vitro effects of anaesthetic agents on the blood-brain barrier]. Anaesthesist 53(12):1177-1184
18. Dantendorfer K, Amering M, Bankier A, Helbich T, Prayer D, Youssefzadeh S, Alexandrowicz R, Imhof H, Katschnig H (1997) A study of the effects of patient anxiety, perceptions and equipment on motion artifacts in magnetic resonance imaging. Magn Reson Imaging 15(3):301-306